View Cart (0 items)

Pharmaceutical

China arrested 186 people for environmental violations in 2013

As part of a nationwide campaign carried out in 2013 by local environmental authorities, over 3,500 businesses and workshops were closed after some 6,500 instances of environmental problems were detected.
Read More

India's drug makers embrace automation

India's second largest drug maker by sales, Dr. Reddy's Laboratories, is embracing automation and making it a critical part of the manufacturing process.
Read More

British scientists discover way to fight antibiotic-resistant bacteria

Thanks to a new study by researchers at the University of East Anglia (UEA), the fight against antibiotic-resistant bacteria may become easier.
Read More

FDA's action against Ranbaxy will cost US consumers

Indian drug-maker Ranbaxy Laboratories Ltd. was supposed to introduce three generic versions of branded products that could potentially save Americans millions of dollars, but problems related to regulation and manufacturing standards are delaying their launch.
Read More

US pharma major Abbott to pay $2.9 billion for Chile's CFR

U.S. pharmaceuticals and healthcare products major Abbott Laboratories has agreed to acquire Chile-based pharmaceutical firm CFR Pharmaceuticals SA in a deal worth $2.9 billion.
Read More

Indian drug maker faces court action over alleged patent infringement

Indian pharmaceutical research company Aurobindo Pharma is facing legal action from three large international competitors that have accused the company of patent infringement.
Read More

EC: Pharmaceutical industry should focus on working with member states

Europe's pharmaceutical industry should do more to convince member states of the industry's strengths, instead of trying to change the European Commission's regulatory policy.
Read More

EU, US health officials team up to fight antimicrobial resistance

Health officials from both sides of the Atlantic have been working together to tackle antimicrobial resistance under their joint Transatlantic Taskforce on Antimicrobial Resistance.
Read More

Pfizer proposes $101 billion takeover to AstraZeneca, reports claim

U.S. pharmaceutical company Pfizer has expressed interest in taking over Anglo-Swedish giant AstraZeneca for a total of $101 billion.
Read More

New FDA import ban hits Indian drug-making industry

The FDA's campaign against substandard pharmaceutical products manufactured in India is continuing with a new import ban, this time imposed on drugs produced at a Bangalore facility owned and operated by Canadian company Apotex Inc.
Read More